Careside Trglyceride
Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides. 510(k) K020488, from Careside, Inc. (Culver City, CA). Product code CDT, class 1.
As of Nov 20, 2026, K020488 is an FDA 510(k) held by Careside, Inc., substantially equivalent on Apr 15, 2002 after 61 days, with no recalls tied to it in FDA's recall database.
- Review time: 61 days
- Recalls: 0
- Cited as a predicate by: 1 device
This product is indicated for use in the diagnosis and treatment of patients with primary or secondary hyperlipidemias. Hyperlipidemias may result from liver obstruction, diseases involving lipid metabolism, or various endocrine disorders. Triglyceride results are used together by the CARESIDE Analyzer with total cholesterol and HDL-cholesterol results to calculate LDL-cholesterol levels.
- Kodak Ektachem Dtii SystemK912844 · Eastman Kodak Company · Sep 4, 1991
- SurgimendK083898 · Tei Biosciences, Inc. · Feb 4, 2009
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 13, 2002
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1705
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files